We have another Infrastructure Week on the schedule and if you had "the filibuster isn't racist" on your 2021 BINGO card, you win a prize. Here's more about what is and isn't expected in the Washington Week Ahead. 

(ANOTHER) INFRASTRUCTURE WEEK: The proverbial joke in Washington is actually, really happening in Pittsburgh on Wednesday when President Joe Biden takes to the stage to pitch his infrastructure plan. The White House has downplayed leaks so far, but we can expect that he'll try to sell the American people on $3-4 trillion in federal spending on "hard infrastructure" like planes, trains, and automobiles and "soft infrastructure" like free community college and universal Pre-K. The bill will not garner much Republican support and Democrats are planning to move forward with another budget reconciliation proposal.

CRICKETS ON CAPITOL HILL: The week of Spring Recess and all through the House, not a creature was stirring, not even a mouse. The Senate gaveled out of its chamber with care in hopes that legislative business would all disappear. 

Yes, I did write a poem about next week in Washington. But it pretty much sums up where things are: Congress is in recess for two weeks and that means exactly nothing will be happening on the legislative front. Don't expect much from the president either. He's clearly in no rush to do anything on gun control or immigration, saying "timing is everything." In other words, not now. 

BESSEMER UNION BATTLE: The vote on whether to unionize the Amazon warehouse in Bessemer, Alabama wraps up on Monday, just days before Biden heads north to the union town of Pittsburgh to pitch the country on tons of good, union jobs as part of his infrastructure plan. But the union fight is already here and it's happening in a state that is historically anti-union. Whether or not Amazon's warehouse does unionize or not, the conversation about union jobs and unions, in general, is going to be an ongoing one, especially as the Democratic Senate will likely force a vote on the pro-union PRO Act despite having no Republican support — if they can get the votes in their own party. 

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More